Head to Head Comparison: Pervasip (OTCMKTS:PVSP) vs. Mind Medicine (MindMed) (NASDAQ:MNMD)

Pervasip (OTCMKTS:PVSP) and Mind Medicine (MindMed) (NASDAQ:MNMD) are both small-cap utilities companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, earnings, profitability, analyst recommendations, risk and institutional ownership.

Analyst Recommendations

This is a summary of recent ratings and price targets for Pervasip and Mind Medicine (MindMed), as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pervasip	0	0	0	0	N/A
Mind Medicine (MindMed)	0	0	7	0	3.00

Mind Medicine (MindMed) has a consensus price target of $17.67, indicating a potential upside of 122.22%. Given Mind Medicine (MindMed)’s higher possible upside, analysts clearly believe Mind Medicine (MindMed) is more favorable than Pervasip.

Risk & Volatility

Pervasip has a beta of 0.35, meaning that its share price is 65% less volatile than the S&P 500. Comparatively, Mind Medicine (MindMed) has a beta of 2.72, meaning that its share price is 172% more volatile than the S&P 500.

Insider and Institutional Ownership

27.9% of Mind Medicine (MindMed) shares are held by institutional investors. 9.2% of Pervasip shares are held by company insiders. Comparatively, 2.3% of Mind Medicine (MindMed) shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Earnings and Valuation

This table compares Pervasip and Mind Medicine (MindMed)’s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pervasip	$15.77 million	0.12	-$2.35 million	N/A	N/A
Mind Medicine (MindMed)	N/A	N/A	-$95.73 million	($2.94)	-2.70

Pervasip has higher revenue and earnings than Mind Medicine (MindMed).

Profitability

This table compares Pervasip and Mind Medicine (MindMed)’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Pervasip	-14.89%	N/A	-26.25%
Mind Medicine (MindMed)	N/A	-84.72%	-59.00%

About Pervasip

Pervasip Corporation focuses on developing cloud-based applications to monitor and control greenhouse facilities. It intends to develop and deliver products and technologies to agricultural markets; develop scientific methods for the analysis of cannabinoids in flowers, concentrates, and edibles; and assist medical marijuana specialty production facilities to regulate, calculate proper dosage, and understand the importance of consistency in product. The company was formerly known as eLEC Communications Corp. and changed its name to Pervasip Corp. in December 2007. Pervasip Corp. was founded in 1964 and is based in White Plains, New York.

About Mind Medicine (MindMed)

Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.